-
Infographic – U.S. Life Science Venture Activity Keeps Falling
Investments in life science start-ups in the U.S. show continued declines into the second quarter of 2023, reaching levels not seen in four or five years.
-
NIH Funding Single Home Test for Covid-19, Influenza, RSV
A developer of diagnostics for infectious and other diseases is receiving a National Institutes of Health contract to advance a single at-home test for multiple respiratory diseases.
-
Venture Fund to Back Life Science A.I. Start-Ups
A new venture fund says it’s investing in health and life science start-ups implementing advanced technologies, particularly artificial intelligence, that promise to transform the field.
-
Trial Underway Testing Dried Plasma for Transfusions
A clinical trial is recruiting participants to assess the safety and feasibility of a system for spray drying and re-constituting a person’s blood plasma.
-
Bio-Friendly Plant Nutrient Delivery Patent Awarded
A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent.
-
Infographic – Venture Funds Continue Slide in Q2
Venture capital funding for start-ups worldwide continued dropping in the second quarter of 2023 with dollar volumes down by double digits from just the first quarter of the year.
-
Digital Biomarkers Shown to Highlight Parkinson’s Disease
Early findings indicate calculations from MRI scans of white matter lesions in the brain can distinguish between Parkinson’s disease and other neurological conditions.
-
A.I.-Enhanced Sensors Start-Up Gains $10.5M in Early Funds
A company developing area sensors for smart homes that combine WiFi technology with machine learning algorithms is raising $10.5 million in venture funds.
-
Biochip Device Tests Malaria Drug Efficacy, Safety
A lab-on-a-chip device with human organ cells is shown in lab tests to distinguish between malaria strains and detect drug toxicity when assessing blood for seven days.
-
Fourth of July 2023
Like most others in the country, we’ll be taking the day off and will resume our normal editorial posts tomorrow.